Correlation Between Johnson Johnson and ADMA Biologics
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and ADMA Biologics, you can compare the effects of market volatilities on Johnson Johnson and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and ADMA Biologics.
Diversification Opportunities for Johnson Johnson and ADMA Biologics
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and ADMA is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and ADMA Biologics go up and down completely randomly.
Pair Corralation between Johnson Johnson and ADMA Biologics
Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.43 times more return on investment than ADMA Biologics. However, Johnson Johnson is 2.35 times less risky than ADMA Biologics. It trades about 0.15 of its potential returns per unit of risk. ADMA Biologics is currently generating about -0.12 per unit of risk. If you would invest 15,115 in Johnson Johnson on December 3, 2024 and sell it today you would earn a total of 1,613 from holding Johnson Johnson or generate 10.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. ADMA Biologics
Performance |
Timeline |
Johnson Johnson |
ADMA Biologics |
Johnson Johnson and ADMA Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and ADMA Biologics
The main advantage of trading using opposite Johnson Johnson and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |